Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration ...

Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration-sensitive prostate cancer (mCSPC) initiating ERLEADA® without docetaxel ...

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...

Each 1-point increase in the 2021 Prostate Cancer Behavior Score was significantly associated with a reduction in all-cause mortality. Healthy lifestyle and dietary choices are associated with a ...

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...

Men with nonmetastatic prostate cancer lived longer if they followed a healthier lifestyle, despite no reduction in prostate cancer-specific mortality, according to a large observational study. A ...

Prostate Cancer Straight Talk led by Jersey City Library Executive Director Terry Hill, boost early screening and support ...